Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial
Fatemeh Jafari
Fatemeh Jafari

Assistant Professor of Radiation Oncology

Imam Khomeini Hospital Complex

Tehran University of Medical Sciences

All Documents
40. Multimodality Treatment in Unresectable Cholangiocarcinoma, Journal of Contemporary Brachytherapy (2020)